127 related articles for article (PubMed ID: 34585873)
1. Periodontal Clinicoradiographic Status and Whole Saliva Soluble Urokinase Plasminogen Activation Receptor and Tumor Necrosis Factor Alpha Levels in Type-2 Diabetic and Non-diabetic Individuals.
Ali D; Qasem SS; Baskaradoss JK
Oral Health Prev Dent; 2021 Jan; 19():481-488. PubMed ID: 34585873
[TBL] [Abstract][Full Text] [Related]
2. Assessment of saliva and gingival crevicular fluid soluble urokinase plasminogen activator receptor (suPAR), galectin-1, and TNF-α levels in periodontal health and disease.
Taşdemir İ; Erbak Yılmaz H; Narin F; Sağlam M
J Periodontal Res; 2020 Oct; 55(5):622-630. PubMed ID: 32166745
[TBL] [Abstract][Full Text] [Related]
3. Levels of peri-implant sulcular fluid levels of soluble urokinase plasminogen activator receptor and TNF-α among cigarette smokers and non-smokers with peri-implantitis.
Dewan H; Robaian A; Divakar DD; Hegde SMR; Shankar SM; Poojary B
Technol Health Care; 2023; 31(1):1-9. PubMed ID: 35848046
[TBL] [Abstract][Full Text] [Related]
4. Correlation between whole salivary prostaglandin E
Shaheen MY; Basudan AM; Alzawawi AS; Al-Ahmari F; Aldulaijan HA; Alshibani N; Shaheen RS; Al-Kattan R
BMC Oral Health; 2024 Feb; 24(1):266. PubMed ID: 38395886
[TBL] [Abstract][Full Text] [Related]
5. Salivary interleukin-17 and tumor necrosis factor-α in relation to periodontitis and glycemic status in type 2 diabetes mellitus.
Gürsoy UK; Yildiz Çiftlikli S; Könönen E; Gürsoy M; Doğan B
J Diabetes; 2015 Sep; 7(5):681-8. PubMed ID: 25327309
[TBL] [Abstract][Full Text] [Related]
6. Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor (suPAR) levels.
Isola G; Polizzi A; Alibrandi A; Williams RC; Leonardi R
J Periodontol; 2021 Jun; 92(6):896-906. PubMed ID: 33091149
[TBL] [Abstract][Full Text] [Related]
7. Periodontal and peri-implant status and whole salivary interleukin 1-beta levels among individuals using selective serotonin reuptake inhibitors: an observational study.
ALHarthi SS; BinShabaib MS; Alwahibi A; Gamal S; Elashiry E; Almershed SE; Alkhamis HA; Anweigi L
BMC Oral Health; 2023 May; 23(1):310. PubMed ID: 37217913
[TBL] [Abstract][Full Text] [Related]
8. Role of PDT as an adjunct to SRP on whole salivary RANKL and OPG ratio in type-2 diabetic and normoglycemic individuals with chronic periodontitis.
Shetty B; Divakar DD; Al-Kheraif AA; Alharbi AO; Almutairi MST; Alanazi MM
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102220. PubMed ID: 33610736
[TBL] [Abstract][Full Text] [Related]
9. Peri-implant Sulcular Fluid Galectin-1, Soluble Urokinase Plasminogen Activator Receptor and IL-1β Levels under Peri-implant Inflammatory Conditions.
Alshiddi IF; AlMubarak AM; Alqutub MN; Alqarawi FK; Alshahrani FA; Javed F; Vohra F; Abduljabbar T
Oral Health Prev Dent; 2021 Jan; 19():503-510. PubMed ID: 34585876
[TBL] [Abstract][Full Text] [Related]
10. Levels of interleukin 1-beta and soluble urokinase plasminogen activation factor in peri-implant sulcular fluid of cement- and screw-retained dental implants.
Ali D
Quintessence Int; 2023 Jun; 54(6):452-458. PubMed ID: 36757310
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase-type plasminogen activator receptor is associated with signs of periodontitis in adolescents.
Skottrup PD; Dahlén G; Baelum V; Lopez R
Eur J Oral Sci; 2018 Aug; 126(4):292-299. PubMed ID: 29752756
[TBL] [Abstract][Full Text] [Related]
12. Levels of advanced glycation end products in gingival crevicular fluid of chronic periodontitis patients with and without type-2 diabetes mellitus.
Akram Z; Alqahtani F; Alqahtani M; Al-Kheraif AA; Javed F
J Periodontol; 2020 Mar; 91(3):396-402. PubMed ID: 31389020
[TBL] [Abstract][Full Text] [Related]
13. Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects.
El-Patal MA; Khalil MA; Shipl W; Barakat I; Youssef EMI; El Attar S; Fathi A; Abdallah AA
BMC Oral Health; 2022 Oct; 22(1):436. PubMed ID: 36192745
[TBL] [Abstract][Full Text] [Related]
14. Role of Chlorhexidine and Herbal Oral Rinses in Managing Periodontitis.
Shaheen MY; Al-Zawawi AS; Divakar DD; Aldulaijan HA; Basudan AM
Int Dent J; 2023 Apr; 73(2):235-242. PubMed ID: 35907673
[TBL] [Abstract][Full Text] [Related]
15. Periodontal Conditions and Whole Salivary IL-17A and -23 Levels among Young Adult
Javed F; Al-Zawawi AS; Allemailem KS; Almatroudi A; Mehmood A; Divakar DD; Al-Kheraif AA
Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33066031
[TBL] [Abstract][Full Text] [Related]
16. The levels of soluble urokinase plasminogen activator receptor (suPAR) in saliva are influenced by acute stress.
Fernandez-Botran R; Szabo YZ; Lyle KB; Newton TL
Biol Psychol; 2021 Oct; 165():108147. PubMed ID: 34492333
[TBL] [Abstract][Full Text] [Related]
17. Comparison of peri-implant soft tissue and crestal bone status of dental implants placed in prediabetic, type 2 diabetic, and non-diabetic individuals: a retrospective cohort study.
Alshahrani A; Al Deeb M; Alresayes S; Mokeem SA; Al-Hamoudi N; Alghamdi O; Vohra F; Abduljabbar T
Int J Implant Dent; 2020 Oct; 6(1):56. PubMed ID: 33015750
[TBL] [Abstract][Full Text] [Related]
18. Influence of root debridement with adjunct photodynamic therapy on periodontal parameters and gingival crevicular fluid cortisol levels among patients with and without type-2 diabetes mellitus.
Al-Zawawi AS; Bukhari IA; Bello-Correa FO; Sheikh SA; Albaijan R; Vohra F
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102076. PubMed ID: 33152543
[TBL] [Abstract][Full Text] [Related]
19. The effect of periodontal therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients.
Dağ A; Firat ET; Arikan S; Kadiroğlu AK; Kaplan A
Aust Dent J; 2009 Mar; 54(1):17-22. PubMed ID: 19228128
[TBL] [Abstract][Full Text] [Related]
20. Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.
Kostopoulou E; Kalavrizioti D; Davoulou P; Sinopidis X; Papachristou E; Goumenos DS; Dimitriou G; Spiliotis BE; Papasotiriou M
Eur J Pediatr; 2024 May; 183(5):2383-2389. PubMed ID: 38448612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
